CAS: 492445-28-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (2S)-2-(4-Acetamidophenyl)-N-(5-propan-2-yl-1,3-thiazol-2-yl)propanamide REF: TR-A345355CAS: 492445-28-0 | - - - | 5,336.00 € | Thu 07 Nov 24 |
 | PHA690509 REF: 3D-SUA44528CAS: 492445-28-0 | Min. 95% | To inquire | Fri 08 Nov 24 |
 | PHA-690509 REF: TM-T19657CAS: 492445-28-0 | 98% | 1,437.00 €~2,309.00 € | Fri 15 Nov 24 |
(2S)-2-(4-Acetamidophenyl)-N-(5-propan-2-yl-1,3-thiazol-2-yl)propanamide
Controlled ProductCAS:492445-28-0
Formula:
C17H21N3O2S
Color and Shape:
Neat
Molecular weight:
331.433
Ref: TR-A345355
| 100mg | 5,336.00 € |
Estimated delivery in United States, on Thursday 7 Nov 2024
PHA690509
CAS:492445-28-0
This is a research reagent that is an activator of the Ligand-Gated Ion channels. It …
Formula:
C17H21N3O2S
Purity:
Min. 95%
Molecular weight:
331.43 g/mol
Ref: 3D-SUA44528
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 8 Nov 2024
PHA-690509
CAS:492445-28-0
PHA-690509 is a cyclin-dependent kinase 2 inhibitor. It potentially for the treatment of cancer.
Formula:
C17H21N3O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
331.43
Ref: TM-T19657
| 25mg | 1,437.00 € | ||
| 50mg | 1,832.00 € | ||
| 100mg | 2,309.00 € |
Estimated delivery in United States, on Friday 15 Nov 2024
